UMP Healthcare Holdings Ltd
HKEX:722
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
UMP Healthcare Holdings Ltd
HKEX:722
|
HK |
|
Aquis Exchange PLC
LSE:AQX
|
UK |
|
Holmen AB
STO:HOLM B
|
SE |
|
Li-Cycle Holdings Corp
NYSE:LICY
|
CA |
|
Metaage Corp
TWSE:6112
|
TW |
|
J
|
Jiangsu Rongtai Industry Co Ltd
SSE:605133
|
CN |
Balance Sheet
Balance Sheet Decomposition
UMP Healthcare Holdings Ltd
UMP Healthcare Holdings Ltd
Balance Sheet
UMP Healthcare Holdings Ltd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
64
|
54
|
85
|
262
|
435
|
294
|
208
|
231
|
294
|
236
|
41
|
196
|
338
|
|
| Cash |
64
|
54
|
85
|
262
|
435
|
0
|
0
|
0
|
0
|
236
|
0
|
148
|
303
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
294
|
208
|
231
|
294
|
0
|
41
|
49
|
35
|
|
| Short-Term Investments |
3
|
3
|
3
|
32
|
17
|
13
|
16
|
37
|
41
|
47
|
82
|
98
|
92
|
|
| Total Receivables |
101
|
112
|
81
|
48
|
69
|
89
|
113
|
78
|
89
|
127
|
141
|
160
|
157
|
|
| Accounts Receivables |
43
|
42
|
45
|
47
|
57
|
79
|
105
|
74
|
83
|
81
|
121
|
131
|
121
|
|
| Other Receivables |
58
|
70
|
36
|
1
|
12
|
10
|
8
|
4
|
6
|
45
|
20
|
29
|
37
|
|
| Inventory |
3
|
6
|
5
|
7
|
7
|
8
|
12
|
9
|
9
|
9
|
12
|
15
|
15
|
|
| Other Current Assets |
4
|
4
|
10
|
9
|
9
|
70
|
22
|
34
|
60
|
14
|
23
|
20
|
25
|
|
| Total Current Assets |
174
|
179
|
183
|
359
|
537
|
474
|
371
|
389
|
493
|
433
|
496
|
489
|
537
|
|
| PP&E Net |
4
|
8
|
27
|
38
|
44
|
104
|
101
|
179
|
173
|
277
|
313
|
320
|
274
|
|
| PP&E Gross |
4
|
8
|
27
|
38
|
44
|
104
|
101
|
179
|
173
|
277
|
313
|
320
|
274
|
|
| Accumulated Depreciation |
29
|
31
|
33
|
38
|
51
|
71
|
85
|
103
|
129
|
135
|
138
|
160
|
182
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
9
|
79
|
77
|
62
|
60
|
48
|
38
|
38
|
|
| Goodwill |
0
|
24
|
28
|
33
|
41
|
58
|
164
|
171
|
165
|
165
|
165
|
164
|
157
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
4
|
2
|
0
|
|
| Long-Term Investments |
11
|
14
|
5
|
62
|
59
|
75
|
110
|
52
|
55
|
64
|
62
|
41
|
49
|
|
| Other Long-Term Assets |
4
|
6
|
6
|
17
|
17
|
17
|
17
|
24
|
22
|
33
|
34
|
53
|
40
|
|
| Other Assets |
0
|
24
|
28
|
33
|
41
|
58
|
164
|
171
|
165
|
165
|
165
|
164
|
157
|
|
| Total Assets |
193
N/A
|
232
+20%
|
250
+8%
|
510
+104%
|
698
+37%
|
738
+6%
|
842
+14%
|
891
+6%
|
970
+9%
|
1 038
+7%
|
1 121
+8%
|
1 107
-1%
|
1 095
-1%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
36
|
38
|
48
|
47
|
54
|
39
|
50
|
36
|
62
|
39
|
64
|
76
|
62
|
|
| Accrued Liabilities |
4
|
7
|
17
|
7
|
6
|
7
|
10
|
11
|
12
|
15
|
14
|
15
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
49
|
52
|
53
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
39
|
63
|
58
|
53
|
56
|
|
| Other Current Liabilities |
36
|
36
|
117
|
43
|
41
|
51
|
80
|
69
|
110
|
77
|
86
|
75
|
83
|
|
| Total Current Liabilities |
76
|
81
|
182
|
97
|
101
|
98
|
139
|
160
|
223
|
194
|
271
|
271
|
269
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
39
|
85
|
65
|
67
|
53
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
1
|
3
|
15
|
15
|
12
|
13
|
9
|
17
|
15
|
|
| Minority Interest |
3
|
1
|
2
|
2
|
63
|
67
|
73
|
59
|
54
|
39
|
29
|
18
|
9
|
|
| Other Liabilities |
1
|
1
|
1
|
2
|
1
|
2
|
3
|
3
|
3
|
7
|
6
|
7
|
7
|
|
| Total Liabilities |
80
N/A
|
83
+3%
|
182
+119%
|
98
-46%
|
166
+70%
|
170
+3%
|
229
+34%
|
279
+22%
|
330
+18%
|
339
+3%
|
381
+12%
|
381
+0%
|
353
-7%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
113
|
149
|
68
|
59
|
177
|
187
|
220
|
240
|
264
|
301
|
325
|
332
|
336
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
353
|
356
|
380
|
388
|
398
|
409
|
423
|
437
|
437
|
437
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
22
|
17
|
7
|
1
|
20
|
10
|
|
| Other Equity |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
16
|
19
|
21
|
24
|
21
|
|
| Total Equity |
113
N/A
|
149
+32%
|
68
-54%
|
412
+509%
|
533
+29%
|
567
+6%
|
613
+8%
|
612
0%
|
639
+5%
|
699
+9%
|
741
+6%
|
726
-2%
|
743
+2%
|
|
| Total Liabilities & Equity |
193
N/A
|
232
+20%
|
250
+8%
|
510
+104%
|
698
+37%
|
738
+6%
|
842
+14%
|
891
+6%
|
970
+9%
|
1 038
+7%
|
1 121
+8%
|
1 107
-1%
|
1 095
-1%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
552
|
552
|
552
|
736
|
737
|
753
|
758
|
766
|
775
|
793
|
811
|
811
|
811
|
|